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Drs Chang and Youn (left to right)r
doi:10.1016/j.jtcvs.2006.10.023bjectives: The Carpentier rigid ring and the Duran flexible ring have been used for
itral valve repair. The Carpentier ring reduces mitral insufficiency very effec-
ively, but it causes minor systolic dysfunction. Meanwhile, the Duran ring inter-
eres less with the normal movements of the mitral annulus during the cardiac cycle
han the Carpentier ring.
ethods: From January 1995 through August 2005, 363 patients underwent mitral
alvuloplasty with annuloplasty rings. We chose the ring with randomization for
itral valve repair, and the data were collected prospectively. Seven patients who
ad undergone re-repair or replacement because of failure of initial repair confirmed
y means of intraoperative transesophageal echocardiography were excluded in this
tudy, and 356 patients were enrolled (Carpentier ring group, n  186; Duran ring
roup, n  170). Mean age was 49.4 years and 50.3 years for the Carpentier and
uran ring groups, respectively. There were no significant differences in age, sex,
ody surface area, or cause of mitral regurgitation between the 2 groups.
esults: There were 4 (1.1%) operative mortalities. The patients were followed
p for 3 to 126 months (mean, 46.6 months), and total follow-up was 1368.2
atient-years. The left ventricular end-diastolic diameter, left ventricular end-
ystolic diameter, and left atrial size were significantly decreased in both groups.
owever, there was no difference in the long-term echocardiographic results
etween the 2 groups. Overall actuarial survivals at 10 years were 85.9% 
.9% in the Carpentier ring group and 75.7%  7.2% in the Duran ring group,
ithout a significant difference. Significant mitral regurgitation (grade 3)
ecurred in 23 patients (Carpentier ring group, 8; Duran ring group, 15). The
-year freedom from recurrence of significant mitral regurgitation was 62.6% 
9.0% in the Carpentier ring group and 55.5%  14.1% in the Duran ring group
P  .172). Independent prognostic factors for recurrence of mitral regurgitation
n logistic regression analysis were preoperative tricuspid regurgitation of grade
or greater and residual mitral regurgitation of grade 2 or greater at the 5th 
th postoperative days.
onclusions: Mitral valvuloplasty favors the excellent surgical and long-term results in
ur prospective randomized study, regardless of the type of annuloplasty ring. There
as no difference between the rigid and flexible rings in terms of left ventricular systolic
unction measured with echocardiography. It seems that timing of the operation before
ignificant tricuspid regurgitation and precise mitral valve repair might prevent late
ecurrence of mitral regurgitation.
The Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 4 995
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A
CDeconstruction of the valve for mitral regurgitation
(MR) has been thought to be the treatment of
choice, even in patients with mild or no symptoms.
umerous long-term studies have demonstrated excellent
esults in terms of being free from reoperation and valve-
elated complications after mitral valve reconstruction.
owever, there are still controversies in the selection of
rosthetic materials for annuloplasty.
Basically, there are 2 types of prostheses: the rigid ring
eveloped by Carpentier and colleagues,1 which restores th
itral annulus to its normal size and shape, and the totally
exible ring developed by Duran and associates,2 which
lso reduces the annular size but allows for it to continu-
usly change during the cardiac cycle.3
Physiologically, the shape and area of the mitral annulus
re changing during the cardiac cycles with ventricular
otion.4 Experimental fixation of the mitral annulus wit
igid ring prosthesis impairs left ventricular systolic func-
ion.5 Also, the same group demonstrated that a flex
nnuloplasty ring results in better left ventricular systolic
unction than a rigid annuloplasty ring 2 to 3 months after
itral valve reconstruction.6 The same results were al
eported by Okada and coworkers3 using echocardiographic
echniques 6 months after mitral valve reconstruction. How-
ver, there are contrary studies7,8 that report no harmfu
ffects with a rigid ring. Also, there is a possibility of a high
ncidence of recurrence of MR with a rather round shape of
exible ring in patients with left ventricular dilatation. Thus
he shape of the mitral annulus, in addition to reduction of
ts area after annuloplasty, might play an important role in
reventing the recurrence of regurgitation. A prospective
linical study was undertaken in a randomized fashion to
nderstand the roles of annuloplasty rings (the ellipsoidal
igid ring and the rather spherical flexible ring) on long-term
esults.
aterials and Methods
rom August 1995 through August 2005, a total of 363 patients
nderwent mitral valve reconstruction by one surgeon (BCC) for
R at Severance Hospital, Yonsei University College of Medi-
ine. In all patients, a classical Carpentier mitral annuloplasty ring
Edwards Lifesciences LLC, Irvine, Calif) or a flexible Duran
nnuloplasty ring (Medtronic, Inc, Minneapolis, Minn) was as-
igned according to a table of random numbers at the time of the
peration. Seven patients (5 patients with the Duran ring and 2
ith the Carpentier ring) were excluded from the study for long-
erm results because of valve replacement (n 5) or re-repair (n
) just after initial reconstruction because of significant MR in
patients or left ventricular outflow stenosis in 1 patient (con-
rmed by means of intraoperative transesophageal echocardi-
graphy).
Of the 356 patients, a Carpentier ring was used in 186 patients,
nd a Duran ring was used in 170 patients. The mean age of the
atients was 49.9 years (range, 17-83 years). There were no
ifferences in sex, age, preoperative New York Heart Association e
96 The Journal of Thoracic and Cardiovascular Surgery ● Apriunctional class, incidence of atrial fibrillation, or cause of regur-
itation (Table 1).
The distribution of the cause of mitral valve disease is listed in
able 1. The main cause of MR was degenerative disease i
66.3%) patients. Other causes were rheumatic in 40 (11.2%)
atients, endocarditis in 17 (4.8%) patients, congenital in 24
6.7%) patients, annular dilatation or dilated cardiomyopathy in 37
10.4%) patients, and trauma in 2 (0.6%) patients. There was no
tatistically significant difference in the causes of MR between the
arpentier group and the Duran group.
urgical Techniques
ransesophageal echocardiography was performed in all patients
fter the induction of anesthesia to evaluate valvular and ventric-
lar function during surgical intervention. All operations were
erformed by one surgeon, and surgical techniques remained sub-
tantially unchanged during the study period. Cardiopulmonary
ypass was performed after achievement of mild systemic hypo-
hermia (30°C-34°C) by using a membrane oxygenator. Myocar-
ial protection was accomplished with a cold blood cardioplegic
olution. The size of the Carpentier annuloplasty ring was selected
ccording to the size of the anterior leaflet; the size of the Duran
ing was based on the intertrigonal distance. The valve reconstruc-
ion was the same in all patients using the French technique
eveloped by Carpentier.9 Mitral annuloplasty rings were im-
lanted with 2-0 Ethibond (Ethicon, United Kingdom) interrupted
orizontal mattress sutures.
Another operative technique that has been used recently is
eochordae formation with a Gore-Tex suture (W. L. Gore &
ssociates, Inc, Flagstaff, Ariz); this is decided according to the
nderlying pathology. After weaning from cardiopulmonary by-
ass, MR was re-evaluated by using transesophageal echocardiog-
aphy. MR greater than grade 2 was considered significant, and the
alve was re-repaired (n  2) or replaced (n  5).
The techniques of mitral valve repair and concomitant opera-
ions are shown in Tables 2 and 3.
atient Follow-up
hree hundred forty-six (97.5%) patients were re-evaluated with
ransthoracic echocardiography on postoperative days 5 through 7
efore discharge from the hospital. Three hundred fifty-two pa-
ients were discharged and followed up periodically by either the
ardiologists, surgeons, or referring physicians. Follow-up was
ccomplished by patient visit, mailing, or telephone contact with
he patient or patient’s family. All patients (100%) were followed
p. Follow-up echocardiography was performed 1 year after the
peration and every third year thereafter. Three hundred thirty-one
94.0%) of the 352 discharged survivors underwent follow-up echo-
ardiography. The mean duration from the operation to follow-up
Abbreviations and Acronyms
CI  confidence interval
HR  hazard ratio
MRmitral regurgitationchocardiography was 26.7  24.1 months.
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A
CDThe mean follow-up period was 46.6  32.6 months (43.0 
1.5 months for the Carpentier ring and 50.6 33.4 months for the
uran ring), and the cumulative follow-up was 1368.2 patient-
ears (663.7 patient-years for the Carpentier ring and 704.5
atient-years for the Duran ring).
tatistical Analysis
alve-related complications were defined in accordance with the
uidelines established by the American Association for Thoracic
urgery and the Society of Thoracic Surgeons. All data are pre-
ented as the mean  standard deviation. The variables of the 2
roups were compared by using the unpaired t test. In the analysis
f serially checked echocardiographic parameters, the Wilcoxon
igned–rank test and the repeated-measures analysis of variance
est were applied. Estimates of survival and event-free survival for
ABLE 1. Patient profile
All
o. of patients 356
ex
Male 197 (55.3%)
Female 159 (44.7%)
ge 49.9  16.0 (17-83)
ean NYHA functional class 2.63 0.76
YHA 3 223 (62.6%)
jection fraction 40% 22 (6.2%)
SA 1.66 0.17
ricuspid regurgitation 3 46 (12.9%)
ortic valve disease 30 (8.4%)
AOD 32 (9.0%)
eart rhythm
Normal sinus 236 (66.3%)
Atrial fibrillation 118 (33.1%)
Atrial flutter 2 (0.6%)
ause
Degenerative 236 (66%.3)
Rheumatic 40 (11.2%)
Endocarditis 17 (4.8%)
Congenital 24 (6.7%)
Annular dilation/DCMP 37 (10.4%)
Trauma 2 (0.6%)
YHA, New York Heart Association; BSA, body surface area; CAOD, coro
ABLE 2. Techniques of mitral valve repair
Carpentier ring Duran ring P value
ing annuloplasty 187 (100%) 170 (100%)
egmental resection of
leaflet
154 (82.4%) 129 (80.6%)
ew chordae formation
with PTFE sutures
43 (23.0%) 40 (23.5%)
hordae shortening 12 (6.4%) 9 (5.3%)
hordae transfer 2 (1.1%) 1 (0.6%)
ommissurotomy 6 (3.2%) 3 (1.8%) .743TFE, Polytetrafluoroethylene.
B
The Journal of Thoraciceoperation and the recurrence of significant MR were calculated
y using the Kaplan–Meier method and are reported with 95%
onfidence limits. Patients were censored (ie, withdrawn from the
tudy at the time of reoperation or at the time of death). The SAS
oftware package (SAS 8.0; SAS Institute, Inc, Cary, NC) was
sed for the statistical power analysis of these results.
Estimates are reported with their standard errors. Comparisons
f the curves were established by using the log–rank test for long-term
esults. To analyze risk factors affecting late mortality, we reviewed
reoperative and intraoperative variables (listed in Tables 1 an
ultivariable Cox proportional hazards regression models were
sed to calculate hazard ratios (HRs) after adjustments were made
or preoperative factors. Model selection was performed with a
ackward stepwise method. HRs and 95% confidence intervals
Carpentier ring Duran ring P value
186 170
104 (55.9%) 93 (54.7%)
82 (44.1%) 77 (45.3%) .819
9.4  1.53 (18-81) 50.3  16.0 (17-83) .458
2.62  0.74 2.64  0.78 .649
115 (61.8%) 107 (62.9%) .894
11 (5.9%) 11 (6.5%) .828
1.65  0.17 1.67  0.17 .503
21 (11.2%) 25 (14.7%) .328
24 (12.8%) 6 (3.5%) .02
20 (10.7%) 12 (7.1%) .23
125 (67.2%) 111 (65.3%)
60 (32.3%) 58 (34.1%)
1 (0.5%) 1 (0.6%) .765
129 (69.4%) 107 (62.9%)
17 (9.1%) 23 (13.5%)
10 (5.4%) 7 (4.1%)
8 (4.3%) 16 (9.4%)
21 (11.3%) 16 (9.4%)
1 (0.5%) 1 (0.6%) .258
artery obstructive disease; DCMP, dilated cardiomyopathy.
ABLE 3. Concomitant operations
Carpentier
ring
Duran
ring P value
ricuspid annuloplasty 24 (12.8%) 30 (17.6%)
oronary artery bypass
grafting
20 (10.7%) 12 (7.1%)
ortic valve replacement 20 (10.7%) 5 (2.9%)
epair of atrial septal defect 4 (2.1%) 4 (2.4%)
aze procedure for atrial
fibrillation
6 (3.2%) 4 (2.4%)
raft interposition of aorta 2 (1.1%) 04entall procedure 2 (1.1%) 1 (0.6) .065
and Cardiovascular Surgery ● Volume 133, Number 4 997
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A
CD95% CIs) were calculated. Results were calculated by using the
tatistical software package SPSS 12.0 (SPSS, Chicago, Ill).
esults
here were 4 operative deaths among the 356 patients
mortality, 1.1%), all of which occurred in the Duran ring
roup. The cause of death was heart failure in 2 patients,
pper gastrointestinal bleeding in 1 patient, and sudden
entricular fibrillation in 1 patient. Two patients underwent
eoperation in the early postoperative period for significant
R caused by valve perforation (Carpentier ring, 1) or
emolysis (Duran ring, 1).
The transthoracic echocardiogram performed on the sev-
nth postoperative days revealed that 20 (5.6%) patients had
reater than grade 2 MR (grade 2, 14 patients; grade 3 or 4,
patients). Among them, 1 patient died postoperatively, 2
atients underwent mitral valve replacement later, and the
thers are under observation.
hanges in Left Ventricular Function
reoperative and postoperative left ventricular ejection frac-
ions, left ventricular dimensions, and left atrial dimensions
re shown in Table 4. All parameters except left 
imensions from the immediate postoperative period to the
ast follow-up at serial echocardiographic examination had
hanged significantly (P  .001). The ejection fraction was
ecreased in the immediate postoperative period; in the late
ollow-up period, it was increased significantly. The left
entricular dimensions were significantly decreased at the
ime of serial echocardiography. The left atrial dimension
as decreased in the immediate postoperative period, but
here was no change at late follow-up. There was no sig-
ificant difference between the 2 rings in the tendency of
hanges of each parameter (repeated-measures analysis of
ariance).
ate Death and Patient Survival
f the 352 patients discharged from the hospital, 21 patients
ied during the follow-up period (late mortality, 5.8%). Of
he 21 deaths, 11 were in the Carpentier ring group (late
ABLE 4. Echocardiographic results
Carpentier ring
Preop Postop
VEF (%)* 62.5 11.8 55.9  13 59
VESD (mm)* 46.2 11.7 42.1  10.1 37
VEDD (mm)* 58.3 12.3 48.6  10.3 48
AD (mm)* 51.1 9.1 44  8.6 43
here were no significant differences between the 2 rings in each para
ostoperative (immediate); f/u, follow-up; LVEF, left ventricular ejection fr
nd-diastolic dimension; LAD, left atrial dimension. *All parameters w
ostoperative and last follow-up at serial examination by means of echocortality, 5.9%), and 10 were in the Duran ring group (late D
98 The Journal of Thoracic and Cardiovascular Surgery ● April
ortality, 6.0%). The 2 most common causes of late death
ere heart failure (n  6) and malignancy (n  5). There
ere 4 unknown causes of late death. Other causes of late
eath were intracranial hemorrhage in 2 patients, acute
yocardial infarction in 1 patient, ventricular arrhythmia in
patient, chronic renal failure in 1 patient, and motor
ehicle accident in 1 patient. There was no significant
ifference between the 2 groups.
The Kaplan–Meier survival in all patients was 93.3% 
.7% at 5 years (Carpentier ring, 95.6%  1.7%; Duran
ing, 91.4%  2.8%) and 77.4%  8.0% at 10 years
Carpentier ring, 85.9%  4.9%; Duran ring, 75.7% 
.2%; Figure 1). There were no statistical differences in
urvival rates between the Carpentier ring group and the
uran ring group (P  .74).
The Cox regression hazard model identified age and an
jection fraction of less than 40% as risk factors for late
eath (Table 5).
Duran ring
/u Preop Postop Last f/u
12.3 63.2  11.9 56.5  14.1 60.2  11.5
9.3 45.8  11.9 41.2  10.5 37.1  8.2
8.3 59.4  11.7 50.6  9.1 50.4  8.2
9.5 52.8  11.2 45.3  9.4 45.9  10
(repeated-measures analysis of variance). Preop, Preoperative; Postop,
n; LVESD, left ventricular end-systolic dimension; LVEDD, left ventricular
hanged significantly (P  .001), except left atrial dimension between
graphy.
igure 1. Actuarial survival. C ring, Carpentier ring group; D ring,Last f
.0 
.1 
.8 
.8
meter
actio
ere curan ring group.
l 2007
et
m
w
t
T
H
T
f
d
i
0
g
g
I
T
T
f
f
r
g
R
R
o
r
r
T
u
w
a
a
9
8
r ical
d
g
w
r
c
.
m
f
F
T
L
R
R
C
p
F
t
p
Chang et al Surgery for Acquired Cardiovascular Disease
A
CDThree hundred ten patients had 50% or greater than 50%
jection fraction preoperatively. The actuarial survival of
he patients was identical to that of the general population
atched by age and sex, but it is lower when the operation
as performed in patients with an ejection fraction of less
han 50% (Figure 2).
hromboembolism and Anticoagulation-related
emorrhage
here were no thromboembolic complications during
ollow-up. Two patients experienced major hemorrhage
uring anticoagulation therapy. Freedom from major bleed-
ng caused by anticoagulation at 10 years was 99.1% 
.7% overall, 100% for patients in the Carpentier ring
roup, and 98.2%  1.3% for patients in the Duran ring
roup (P  .16).
ABLE 5. Cox regression analysis
P value Hazard ratio 95% CI
ate death
Age .001 1.09 1.04-1.14
LVEF 40% .030 5.37 1.17-24.54
eoperation
Postop MR 2 .003 20.67 2.72-156.8
ecurrence of mitral
regurgitation
Preop TR 3 .03 6.18 1.44-33.4
Postop MR 2 .001 12.26 3.21-46.83
I, Confidence interval; LVEF, left ventricular ejection fraction; Postop,
ostoperative; Preop, preoperative.
igure 2. Actuarial survival according to preoperative left ven-
ricular ejection fraction (gray line, actuarial survival of generalDopulation matched by age and sex). EF, Ejection fraction.
The Journal of Thoracicnfective Endocarditis
hree patients had infective endocarditis, and 1 patient died.
wo patients were treated with antibiotics alone. Freedom
rom infective endocarditis at 10 years was 98.6%  0.9%
or all patients, 98.7% 0.9% for patients in the Carpentier
ing group, and 98.6% 1.4% for patients in the Duran ring
roup (P  .56).
eoperation
eoperation was required in 8 patients. The causes of re-
peration were progression of MR in 5 patients (Carpentier
ing, 1; Duran ring, 4), hemolysis in 2 patients with a Duran
ing, and endocarditis in 1 patient with a Carpentier ring.
he mitral valves were replaced in all 6 patients who had
ndergone valve repair with a Duran ring. The mitral valves
ere re-repaired in 2 patients with a Carpentier ring (1 with
chordae rupture and 1 with endocarditis).
Kaplan–Meier analysis for freedom from reoperation in
ll patients was 99.3%  1.7% at 5 years (Carpentier ring,
9.5%  0.5%; Duran ring, 95.7%  2.3%) and 77.4% 
.0% at 10 years (Carpentier ring, 95.5%  3.9%; Duran
ing, 86.1%  7.9%; Figure 3). There were no statist
ifferences in survival rates between the Carpentier ring
roup and the Duran ring group (P  .174).
In regard to the causes of MR, freedom from reoperation
as 98.2%  1.4% in degenerative MR, 92.3%  7.4% in
heumatic MR, and 76.9%  17.5% in MR caused by
ardiomyopathy at 7 years (degenerative vs rheumatic, P 
45; degenerative vs cardiomyopathy, P  .0.005; rheu-
atic vs cardiomyopathy, P  .07), and 10-year freedom
rom reoperation in degenerative MR was 87.6%  8.1%.
igure 3. Freedom from reoperation. C ring, Carpentier ring group;
ring, Duran ring group.
and Cardiovascular Surgery ● Volume 133, Number 4 999
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1
A
CDThe Cox proportional hazard model identified MR equal
o or greater than grade 2 at the early postoperative period
s a risk factor for reoperation (Table 5).
ecurrence of Significant MR
ecurrence of significant MR equal to or greater than grade
during the follow-up period occurred in 23 patients (Car-
entier ring, 8; Duran ring, 15). Among them, 5 patients
equired reoperation.
Freedom from significant MR was 92.7%  2.2% at 4
ears (Carpentier ring, 95.0%  2.3%; Duran ring, 90.8%
3.7%) and 59.1%  11.5% at 8 years (Carpentier ring,
2.6%  19.0%; Duran ring, 55.5%  14.1%; Figure 4)
here were no statistical differences in the recurrence of
ignificant MR between the Carpentier ring group and the
uran ring group (P  .172). The statistical power () of
urvival analysis in terms of the recurrence of MR was
erformed to determine whether there was enough power in
his model, and it was .751.
In patients with degenerative disease, we analyzed free-
om from recurrence of significant MR for the evaluation of
he disease progression. Freedom from the recurrence of
ignificant MR in patients with degenerative disease was
5.5%  2.2% at 4 years and 53.8%  17.8% at 8 years.
reedom from the recurrence of significant MR according to
he presence of early residual MR (residual MR 1 vs
esidual MR 2) was analyzed and found to be 97.6% 
.7% in the group with residual MR of grade 1 or less and
igure 4. Freedom from recurrence of significant mitral regurgi-
ation (MR; grade>3). C ring, Carpentier ring group; D ring, Duran
ing group.0.0%  25.0% in the group with residual MR of grade 2 t
000 The Journal of Thoracic and Cardiovascular Surgery ● Aprr greater at 4 years and 55.4%  23.1% in the group with
esidual MR of grade 1 or less and 25.0%  21.7% in the
roup with residual MR of grade 2 or greater at 8 years
P  .01).
The Cox regression hazard model identified preoperative
ricuspid regurgitation of grade 3 or greater and MR of
rade 2 or greater in the immediate postoperative period as
isk factors for the recurrence of significant MR (Tabl
e reanalyzed the late failure of MR repair, excluding the
arly postoperative residual MR (grade 2) because resid-
al MR so strongly related to late MR. The preoperative and
ntraoperative independent predictors for the recurrence of
ignificant MR included dilated cardiomyopathy (HR, 24.5;
5% CI, 5.7104.5), chordae shortening technique (HR,
.5; 95% CI, 2.027.9), new chordae formation technique
HR, 5.0; 95% CI, 1.418.1), male sex (HR, 2.7; 95% CI,
.07.4), and age by increment of 1 year (HR, 1.05; 95%
I, 1.011.09).
iscussion
illehei and associates10 introduced the concept of annul-
lasty in 1957; subsequent suture annuloplasty techniques
ere developed by Reed and coworkers11 and Kay and
gerton.12 An improved approach that began to address 
ore complex leaflet pathology was pioneered by Carpen-
ier and colleagues.13 As Carpentier’s results were dup-
ated, studies began to demonstrate numerous advantages of
alve repair over valve replacement. These advantages in-
luded improved maintenance of left ventricular function,
ower risk of thromboembolism and anticoagulant-related
omplications, reduced risk of endocarditis, and increased
reedom from all valve-related complications. Subsequently,
he long-term durability of valve repair became firmly es-
ablished, and the various advantages of repair over replace-
ent led to an acceptance of valve repair as the preferred
reatment of mitral insufficiency.14
This study was designed to compare the long-term re-
ults between rigid and flexible rings. Freedom from reop-
ration and recurrence of MR were somewhat lower in the
uran ring group, but this difference did not reach statistical
ignificance. Among 8 patients who required reoperation,
he cause of recurrence of MR in 2 patients was the elon-
ation of the anterior–posterior diameter of the mitral an-
ulus because of the morphologic deformation of the Duran
ing, which resulted in the inability to achieve annular
xation; however, it is unclear why the recurrence and
eoperation rate is higher in the Duran ring group. More
ong-term data might be required to make a conclusion on
he longevity of different annuloplasty ring types.
Although flexible annuloplasty devices preserve the nor-
al annular motion and orifice area during the cardiac
ycle, this benefit might be offset by their decreased ability
o geometrically remodel the annulus, which could have a
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A
CDegative effect on late repair durability. David and associ-
tes6 showed that patients with flexible ring annulopla
ave better left ventricular systolic function 2 to 3 months
ostoperatively, but this difference disappears after 1 year.
eanwhile, van Rijk–Zwikker and coworkers8 demon-
trated that there were minimal differences of mural leaflet
otion and diastolic filling of the basal part of the left
entricle between the rigid and flexible rings in an animal
tudy. These kinds of data were also identified by the
tanford group.7 They demonstrated no significant diffe-
nces between rigid and flexible rings in terms of left
entricular systolic performance and energetics 1 and 6
eeks after the operation. According to our late follow-up
chocardiographic data, mitral valve repair with an annulo-
lasty ring improved the left ventricular ejection fraction
nd reduced left ventricular dimension, but there were no
tatistical differences between the degrees of change of
hese parameters between the 2 groups.
Recently, minimally invasive surgery for functional MR
fter myocardial infarction or idiopathic dilated cardiomy-
pathy focused on mitral annular shape.15 The tethering
ffect of the posterior mitral leaflet with enlargement of the
eft ventricular cavity in ischemic or idiopathic dilated car-
iomyopathy results in MR. The fundamental surgical con-
ept of dilated cardiomyopathy was to reduce the mitral
nnulus,16,17 especially the anterior–posterior diameter 
he mitral annulus, with coaptation of the anterior and
osterior leaflet. In this point of view, mitral annulus shape,
s well as size, is thought to be very important to long-term
utcome. In this series we could not find any significant
ifferences in Kaplan–Meier survival, freedom from reop-
ration, and recurrence of significant MR. However, there
as less incidence of recurrence of significant MR in the
arpentier group without significance (P .172). Therefore
t seemed that annuloplasty with a rigid ring might prevent
he recurrence of MR with prevention of elongation of the
nterior-posterior diameter of the mitral valve.
Even though the causes of MR were heterogeneous, it
eems that the causes of MR have little influence on the
esults. The most common cause of MR was degenerative
isease. Mitral valve repair is most applicable to patients
ith degenerative mitral valve disease, with successful val-
uloplasty possible in 95% of such patients.18 Furthermore,
itral valve repair in these patients has its greatest durabil-
ty. Deloche and colleagues19 found that the 15-year fre-
om from reoperation after mitral valve repair was 93% in
atients with degenerative disease; this is similar to our
esults. The second most common cause of MR was rheu-
atic disease. The appropriateness of valve repair for pa-
ients with rheumatic mitral valve disease (even when repair
ppears to be technically feasible) is controversial.20 How-
ver, Yau and associates21 reported that 10-year freedom
rom reoperation was 87%, and rheumatic mitral valves e
The Journal of Thoracichould be repaired when technically feasible, accepting a
isk of reoperation to maximize survival and reduce mor-
idity. Even though only a few rheumatic patients (11.2%)
ere included in this study, there were no late reoperations
n patients with rheumatic disease. Most patients with rheu-
atic mitral stenosis underwent mitral valve replacement
ecause of advanced stage with severe calcification in our
ospital. However, mitral valve repair has been recom-
ended in cases of significant MR, even with severe fibro-
is. We think that precise preoperative evaluation of the
alvular apparatus and careful decision making considering
he feasibility of mitral valve repair in these patients led to
uch a good result.
The Cox regression hazard model revealed that the most
otent risk factor for recurrence of significant MR after
itral repair was residual MR observed at the fifth to
eventh postoperative days. Flameng and coworkers22 re-
orted that when recurrence of any degree of regurgitation,
e it minor, moderate, or severe, is considered, only about
0% of patients remain free from more than trivial mitral
ncompetence at 7 years after repair. These findings strongly
uggest a progression of the disease process with time that
esults in an increasing degree of valve incompetence.
Even though this study was designed as a prospective
nd randomized study, the number of patients in both
roups was somewhat different. The reason is that 7 patients
ncluded initially in this study were excluded later because
hey underwent reoperation because of residual MR dem-
nstrated by means of intraoperative transesophageal echo-
ardiography. However, during the analysis, the patients
ere excluded because of removal of bias of long-term
esults. Including the 7 patients who were excluded from
his study, freedom from significant MR was 57.9% 
1.2% at 8 years (Carpentier ring, 61.8%  18.8%; Duran
ing, 53.7%  13.7%). Also, there were no statistical dif-
erences in the recurrence of significant MR between the
arpentier ring group and the Duran ring group (P  .072).
owever, there was a trend toward difference with time
etween the groups. There might be a possibility of a
ignificant difference in recurrence of significant MR be-
ween 2 groups with longer follow-up.
In patients with rheumatic MR, the long-term results
ere better than others. There might be a selection bias for
itral valve repair. Most patients with rheumatic MR com-
ined with stenosis underwent mitral valve replacement.
herefore the long-term results might be excellent. There
as no significant difference between the 2 types of pros-
hetic rings in early and long-term results. In this study the
umber of patients with cardiomyopathy was too small for
tatistical analysis, and further study should be necessary.
In conclusion, in this prospective and randomized study,
e compared the effects of 2 different annuloplasty rings onarly and long-term clinical results in patients with MR.
and Cardiovascular Surgery ● Volume 133, Number 4 1001
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1
A
CDitral valve annuloplasty with both rings showed good
ong-term clinical results. There were no statistical clinical
ifferences between the Carpentier ring and the Duran ring,
nd follow-up echocardiography demonstrated that both
arly and late postoperative left ventricular dimensions were
ignificantly reduced and that left ventricular function was
ignificantly improved in both groups. More long-term data
ight be required to determine the superiority of either of
he rings. Meticulous operative skills and intraoperative
ransesophageal echocardiographic evaluation are manda-
ory to prevent the late recurrence of MR.
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iscussion
r Aubrey C. Galloway, Jr (New York, NY). This was a very nice
resentation, and I congratulate you on doing a randomized trial,
hich we have too often been unable to do in this country. I do
ave some comments and questions.
The first comment is that this study includes a mixed group of
atients, which limits your ability to draw conclusions. Although
6% of the patients had degenerative disease, 10% were rheu-
atic, and 10% had ischemic or dilated cardiomyopathy. The latter
roup really has a different mechanism for insufficiency than the
egenerative patients, and they consequently have a different
echanism for late repair failure. These 2 groups really need to be
valuated separately.
For example, the patients with ischemic or dilated cardiomy-
pathy and functional MR had roughly a 25% failure rate for
eoperation at 5 to 8 years. Did you see a difference in the rigid
ersus flexible rings in that group? Others have found that patients
ith ischemic or dilated cardiomyopathy have better results when
igid or semirigid devices are used.
Second, even when you looked at the overall freedom from
eoperation and included all of the patients, there was roughly a
0% difference favoring the rigid group. Likewise, when you
ooked at freedom from recurrent 3 or 4 MR, there was a
ifference favoring the rigid ring group, yet these differences were
ot statistically significant. Unfortunately, the study is underpow-
red to detect small or even moderate differences.
The third comment and question has to do with the way you
nalyzed the degenerative patients. We suspect that degenerative
atients would be less likely to have a difference in durability
ased on the type of annuloplasty because late repair failure in
hese patients is more often thought to be due to surgical technique
r leaflet pathology, such as repair of anterior versus posterior
eaflet pathology or rheumatic versus degenerative status. I did not
ee repair of anterior leaflet pathology mentioned. Did you look at
oth repair techniques and pathology in your analysis?
Finally, because you used early postoperative residual MR as a
ariable for your late failure analysis, I think this might have
kewed your results because the variable of early postoperative
nsufficiency might have overwhelmed any other factors that might
ave been significant. Obviously, patients who had significant
arly residual MR would be more likely to fail late. Did you
nalyze the degenerative group in terms of looking at only the
reoperative or intraoperative variables, such as technique or pa-
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Chang et al Surgery for Acquired Cardiovascular Diseasehology, as predictors of failure? It might have been more helpful
ot to include early postoperative MR in the analysis.
Again, congratulations on a nice trial and the overall good
esults achieved.
Dr Chang. Thank you very much for your excellent questions
nd comments. For the first question, we suspected that there were
ome differences between the rigid ring and the flexible ring in the
ohort with dilated cardiomyopathy compared with in the cohorts
f idiopathic or ischemic origin. However, as you commented,
here were only 40 patients with cardiomyopathy. We had ana-
yzed the differences in the cardiomyopathy group with other
roups, and we could not find any significant differences. How-
ver, the rigid ring favored the long-term results in recurrence of
ignificant MR. We need more studies with more patients.
For the second question, we found that there were no differ-
nces in the long-term results between the anterior mitral leaflet
roblems and the posterior mitral leaflet problems. Since the late
990s, we have used Gore-Tex sutures for new chordae formation.
e could not find any differences between the anterior and pos-
erior mitral leaflet pathology in terms of long-term results.
Dr Alain F. Carpentier (Paris, France). I rise to congratulate
ou on this sort of study, which is very necessary, a randomized
tudy, very well done, and I think it is the first, as far as I know,
oncerning the comparison between a flexible and rigid ring. Now
here is no surprise that both rings provided a pretty good result
ecause they are based on the same concept of circular annulo-
lasty as opposed to posterior support. However, based on new
ata, it is remarkable that we see a trend in favor of rigid remod-
ling annuloplasty, and this difference might increase with time, as
hown by your curves, and might be also improved by using a
hysio ring, which is more or less a ring that had 2 advantages of
ertainly flexibility but a remodeling concept. Therefore my only
uestion, after having congratulated you, is whether you have used
r whether you plan to use a Physio ring to see whether there is a
ifference with these 2 well-known rings.Again, congratulations, and thank you very much.
The Journal of ThoracicDr Chang. Thank you very much, Professor Carpentier. It was
great comment for me. We actually wanted to use the Physio ring
t the time of it being commercially available. However, we
uspected that there were minor problems of recurrence of MR
ith some elongation of the annulus. Although we attempted to
oapt the anterior leaflet to the posterior leaflet, we might suspect
hat the annulus dilates a little bit more than expected during
iastole, and we suspected there might be some recurrence of MR.
hus we have used the classical rigid Carpentier rings. I think the
igid ring might have better results in cases of dilated cardiomy-
pathy, idiopathic as well as ischemic. Thank you very much, sir.
Dr Carlos Duran (Missoula, Mont). I rise to comment on this
rticle, primarily because I knew that there were going to be a lot
f people, and if they saw my face, they would expect I would
ave to say something. Basically, what I think is that there is not
hat much difference. And there is a tendency, a lot of it made by
ndustry, of getting a new type of ring or band every few months.
do not know how many there are now available worldwide; there
ust be right around 30 to 40 types of rings. I think we are fussing
oo much about the ring and forgetting that the ring is the final
hing of repair, and if your repair is bad, do not expect that the ring,
hatever type of ring, is going to compensate for your incompe-
ence or my incompetence. Therefore every time that someone
omes along with a new ring, I say, that is fine, go ahead. The
cientific basis behind this in 90% of the cases is completely
bsent. There is no reason except a picture or a fashion; you
uddenly discover the mitral valve has the shape of a saddle, so
ou make a saddle shape. If tomorrow there is another great
dvance in the knowledge of the mitral valve, and it turns out that
n a particular pathology one area is much higher than another, just
hange the ring. But do not forget that the ring does not solve a bad
epair.
I congratulate the authors. This type of work is absolutely
ssential, and I hope you continue doing it and add other types of
ings into the study. Thank you very much.Dr Chang. Thank you, sir.
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